Anika Therapeutics Reports First-Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Anika Therapeutics (ANIK) Tops Q1 EPS by 2c
April 28, 2015 4:24 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $15.5 million versus the consensus estimate of $16.2 million.
Our strong momentum continued throughout the first quarter as we made excellent clinical, regulatory, and commercial... More
